Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4769)
All Articles published online
|
Publishing Process of This Article
|
Sep 14, 2021 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lee CC, Kuo YC, Hu JM, Chang PK, Sun CA, Yang T, Li CW, Chen CY, Lin FH, Hsu CH, Chou YC. MTNR1B polymorphisms with CDKN2A and MGMT methylation status are associated with poor prognosis of colorectal cancer in Taiwan. World J Gastroenterol 2021; 27(34): 5737-5752 [PMID: 34629798 DOI: 10.3748/wjg.v27.i34.5737] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i34/5737.htm |
| Number | Citing Articles |
| 1 |
Yang Li, Ru-yao Wang, Yu-jiao Deng, Shao-hua Wu, Xinti Sun, Hong Mu. Molecular characteristics, clinical significance, and cancer immune interactions of cuproptosis and ferroptosis-associated genes in colorectal cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.975859
|
| 2 |
Kinga Linowiecka, Andrzej T. Slominski, Russel J. Reiter, Markus Böhm, Kerstin Steinbrink, Ralf Paus, Konrad Kleszczyński. Melatonin: A Potential Regulator of DNA Methylation. Antioxidants 2023; 12(6): 1155 doi: 10.3390/antiox12061155
|
| 3 |
Di Zhang, Tao Wang, Yi Zhou, Xipeng Zhang. Comprehensive analyses of cuproptosis-related gene CDKN2A on prognosis and immunologic therapy in human tumors. Medicine 2023; 102(14): e33468 doi: 10.1097/MD.0000000000033468
|
| 4 |
Qian-Qian Wang, Yuan-Chen Zhou, Yu-Jia Zhou Ge, Geng Qin, Teng-Fei Yin, Dong-Yan Zhao, Chang Tan, Shu-Kun Yao. Comprehensive proteomic signature and identification of CDKN2A as a promising prognostic biomarker and therapeutic target of colorectal cancer. World Journal of Clinical Cases 2022; 10(22): 7686-7697 doi: 10.12998/wjcc.v10.i22.7686
|
| 5 |
Mirjam E. van de Velde, Aniek Uittenboogaard, Wenjian Yang, Erik Bonten, Cheng Cheng, Deqing Pei, Marleen H. van den Berg, Inge M. van der Sluis, Cor van den Bos, Floor C. H. Abbink, Marry M. van den Heuvel-Eibrink, Heidi Segers, Christophe Chantrain, Jutte van der Werff ten Bosch, Leen Willems, William E. Evans, Gertjan J. L. Kaspers. Genetic Polymorphisms Associated with Vincristine Pharmacokinetics and Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology Patients. Cancers 2022; 14(14): 3510 doi: 10.3390/cancers14143510
|
| 6 |
Zena Saleh, Matthew C. Moccia, Zachary Ladd, Upasana Joneja, Yahui Li, Francis Spitz, Young Ki Hong, Tao Gao. Pancreatic Neuroendocrine Tumors: Signaling Pathways and Epigenetic Regulation. International Journal of Molecular Sciences 2024; 25(2): 1331 doi: 10.3390/ijms25021331
|
| 7 |
Ziming Wu, Jie Dai, Jie Li, Zhengyu Zhang, Xbing Shen. Exploiting the role of O6-methylguanine-DNA-methyltransferase (MGMT) in gastrointestinal cancers. Naunyn-Schmiedeberg's Archives of Pharmacology 2024; doi: 10.1007/s00210-024-03365-4
|
| 8 |
Yang Lu, Qiang Cao, Yue Yu, Yazhou Sun, Xuan Jiang, Xin Li. Pan-cancer analysis revealed H3K4me1 at bivalent promoters premarks DNA hypermethylation during tumor development and identified the regulatory role of DNA methylation in relation to histone modifications. BMC Genomics 2023; 24(1) doi: 10.1186/s12864-023-09341-1
|
| 9 |
Ke Zheng, Xiu-Xia Zhang, Xin Yu, Bin Yu, Yi-Fei Yang. Identification and validation of a prognostic anoikis-related gene signature in papillary thyroid carcinoma by integrated analysis of single-cell and bulk RNA-sequencing. Medicine 2024; 103(19): e38144 doi: 10.1097/MD.0000000000038144
|